M&A Deal Summary |
|
|---|---|
| Date | 2014-09-29 |
| Target | SAGE Labs |
| Sector | Life Science |
| Buyer(s) | Horizon Discovery Group |
| Sellers(s) | Telegraph Hill Partners |
| Deal Type | Add-on Acquisition |
| Deal Value | 48M USD |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Founded | 2007 |
| Sector | Healthcare Services |
| Employees | 398 |
| Revenue | 58M GBP (2019) |
Horizon Discovery Group PLC is an international life science company supplying research tools and services to organizations engaged in genomics research and the development of personalized medicines. Horizon Discovery Group was founded in 2007 and is based in Cambridge, the United Kingdom.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 3 |
| Sector (Life Science) | 1 of 2 |
| Type (Add-on Acquisition) | 1 of 2 |
| State (Missouri) | 1 of 1 |
| Country (United States) | 2 of 2 |
| Year (2014) | 2 of 2 |
| Size (of disclosed) | 1 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-05-15 |
Zalicus - CombinatoRx Service Business
United States Zalicus, Inc. - CombinatoRx Service Business is a provider of access to the unique cHTS platform and Chalice analytics software, which enables the screening and analysis of thousands of complementary drug combinations. |
Buy | $8M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-01-08 |
Haplogen Genomics
Vienna, Austria Haplogen Genomics GmbH is a biotechnology company generate precisely engineered human cell lines efficiently and at a price that places genome editing within the reach of the broader academic research market through the use of haploid cells. |
Buy | €8M |
| Category | Venture Capital Firm |
|---|---|
| Founded | 2001 |
| Size | Middle-Market |
| Type | Sector Focused |
Telegraph Hill Partners is a specialist private equity firm focused on investing in later-stage life science, medical device, and healthcare companies. Prospective companies should be at or near profitability and demonstrate success. Other areas of interest within the healthcare sector include life science technologies, chemistry/reagent suppliers, and information management. Telegraph Hill Partners was formed in 2001 and is based in San Francisco, California.
| DEAL STATS | # |
|---|---|
| Overall | 17 of 28 |
| Sector (Life Science) | 7 of 12 |
| Type (Add-on Acquisition) | 14 of 23 |
| State (Missouri) | 1 of 1 |
| Country (United States) | 17 of 27 |
| Year (2014) | 2 of 3 |
| Size (of disclosed) | 10 of 13 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-05-30 |
Agena Bioscience
San Diego, California, United States Agena Bioscience is a life science and clinical diagnostics company that offers the MassARRAY® System. The system is a highly sensitive, quantitative method for nucleic acid detection via MALDI-TOF mass spectrometry for high-throughput genotyping and mutation profiling for cancer and other disease research, companion diagnostics, pharmacogenomics, epigenetics, clinical genetics, ag-bio genetics, and biobanking molecular sample identification. Agena Bioscience was established in 2014 and is based in San Diego, California. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2014-12-04 |
PneumRx
Mountain View, California, United States PneumRx, Inc. is a medical device company focused on the development and commercialization of innovative products to treat emphysema using minimally invasive techniques. PneumRx was formed in 2004 and is based in Mountain View, California. |
Sell | $475M |
